Robert Tepper, M.D.
Bob Tepper is a co-founder of Third Rock Ventures and a distinguished scientist with more than 30 years of experience building and operating leading R&D organizations in the biotech industry. Bob focuses on the formation, development and scientific strategy of our portfolio companies, as well as actively identifying and evaluating new investments. He has also assumed active leadership roles in a number of our portfolio companies:
- Board member and former interim CSO of Neon Therapeutics
- Board member of Allena
- Board member and former interim CSO of Constellation Pharmaceuticals
- Board member and former interim CSO of Jounce Therapeutics
- Board member of Kala Pharmaceuticals
- Former board member of Alcresta
- Former board member of Alnara Pharmaceuticals (sold to Eli Lilly)
- Former board member of bluebird bio
Prior to joining Third Rock, Bob was president of R&D at Millennium Pharmaceuticals and was vital in its expansion from a drug discovery company to a fully integrated biopharmaceutical company. Earlier, Bob co-founded Cell Genesys/Abgenix. Bob holds an A.B. in biochemistry from Princeton University and received his M.D. from Harvard Medical School. Bob currently serves as an adjunct faculty member at Harvard Medical School and Massachusetts General Hospital and is an advisory board member of several leading health care institutions, including the Partners HealthCare Center for Personalized Genetic Medicine, Harvard Medical School and Tufts Medical School. Bob is on the Board of Overseers at Tufts University. He also serves on the Council of the National Center for the Advancement of Translational Sciences (NCATS) at the National Institutes of Health (NIH).
Bob participated in the 1972 Olympic Games in Munich, Germany.